The kidney involvement is a key problem (50%) in SLE, and responsible for a high morbidity and mortality. Early detection and treatment can significantly alter the course of LN and enhance long-term survival.Urinary (u)biomarkers are new markers that can distinguish LN activity, severity, predict renal flares, and monitor therapy response and progression. Because they are derived from urinary tissues, they can reflect the current disease situation.This...